EEG Biomarkers to Predict Response to Sertraline and Placebo Treatment in Major Depressive Disorder
Sign Up to like & getrecommendations! Published in 2022 at "IEEE Transactions on Biomedical Engineering"
DOI: 10.1109/tbme.2022.3204861
Abstract: Objective: Major depressive disorder (MDD) is a persistent psychiatric condition, and the leading cause of disability, affecting up to 5% of the population worldwide. Antidepressant medications (ADMs) are often the first-line treatment for MDD, but… read more here.
Keywords: response sertraline; treatment; sertraline placebo; sertraline ... See more keywords